These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 16868809)

  • 1. Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension.
    Wang YW; Lin HC; Yang YY; Hou MC; Lee SD
    J Gastroenterol; 2006 Jun; 41(6):593-7. PubMed ID: 16868809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of severe portopulmonary hypertension in a patient with Child C cirrhosis by sildenafil.
    Callejas Rubio JL; Salmerón Escobar J; González-Calvín J; Ortego Centeno N
    Liver Transpl; 2006 Apr; 12(4):690-1. PubMed ID: 16555327
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel use of sildenafil in the treatment of portopulmonary hypertension.
    Chua R; Keogh A; Miyashita M
    J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension.
    Sağ S; Yeşilbursa D; Güllülü S
    Turk J Gastroenterol; 2014 Aug; 25(4):429-32. PubMed ID: 25254528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation.
    Cadden IS; Greanya ED; Erb SR; Scudamore CH; Yoshida EM
    Ann Hepatol; 2009; 8(2):158-61. PubMed ID: 19502663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary hypertension complicating portal hypertension: portopulmonary hypertension].
    Katsuta Y; Zhang XJ; Aramaki T
    Nihon Rinsho; 2001 Jun; 59(6):1186-92. PubMed ID: 11411134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation.
    Makisalo H; Koivusalo A; Vakkuri A; Hockerstedt K
    Liver Transpl; 2004 Jul; 10(7):945-50. PubMed ID: 15237383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate and long-term hemodynamic and clinical effects of sildenafil in patients with pulmonary arterial hypertension receiving vasodilator therapy.
    Bhatia S; Frantz RP; Severson CJ; Durst LA; McGoon MD
    Mayo Clin Proc; 2003 Oct; 78(10):1207-13. PubMed ID: 14531479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portopulmonary hypertension: short review.
    Stauber RE; Olschewski H
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):385-90. PubMed ID: 19907338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to Sildenafil in a Patient With Coexisting Post-Liver Transplant Portopulmonary Hypertension and Hepatopulmonary Syndrome.
    Turgeon RD; Hussaini T; Partovi N; Erb SR; Nador R; Marquez Azalgara V; Yoshida E
    Exp Clin Transplant; 2017 Dec; 15(6):693-695. PubMed ID: 27001306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bosentan for the treatment of portopulmonary hypertension.
    Tempe DK; Datt V; Datta D
    Ann Card Anaesth; 2008; 11(2):139-40; author reply 140. PubMed ID: 18603763
    [No Abstract]   [Full Text] [Related]  

  • 12. Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis.
    Clemmesen JO; Giraldi A; Ott P; Dalhoff K; Hansen BA; Larsen FS
    World J Gastroenterol; 2008 Oct; 14(40):6208-12. PubMed ID: 18985812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
    Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil Monotherapy to Treat Portopulmonary Hypertension Before Liver Transplant.
    Cheng CH; Wang YC; Wu TH; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC
    Transplant Proc; 2019 Jun; 51(5):1435-1438. PubMed ID: 31079941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
    Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH
    Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension.
    Gough MS; White RJ
    Liver Transpl; 2009 Jan; 15(1):30-6. PubMed ID: 19109844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sildenafil treatment for portopulmonary hypertension.
    Reichenberger F; Voswinckel R; Steveling E; Enke B; Kreckel A; Olschewski H; Grimminger F; Seeger W; Ghofrani HA
    Eur Respir J; 2006 Sep; 28(3):563-7. PubMed ID: 16807265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension.
    Austin MJ; McDougall NI; Wendon JA; Sizer E; Knisely AS; Rela M; Wilson C; Callender ME; O'Grady JG; Heneghan MA
    Liver Transpl; 2008 Mar; 14(3):287-91. PubMed ID: 18306330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatopulmonary syndrome and portopulmonary hypertension: what's new?
    Colle I; Van Steenkiste C; Geerts A; Van Vlierberghe H
    Acta Gastroenterol Belg; 2007; 70(2):203-9. PubMed ID: 17715635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.